[Long QT syndrome in children: analysis of the Lyon series]

M Iraqi1, P Chevalier, M J Raboisson

  • 1Service de cardiologie pédiatrique, Hôpital Louis Pradel, Lyon. meryem.iraqi@free.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 25, 2006
PubMed

Insights

Congenital long QT syndrome (LQTS) in children is serious. Genetic testing aids diagnosis but should complement clinical and ECG data, as some patients lack mutations yet experience severe cardiac events.

Area of Science:

  • Pediatric Cardiology
  • Molecular Genetics
  • Clinical Electrophysiology

Context:

  • Congenital long QT syndrome (LQTS) is a rare but severe pediatric cardiac disorder.
  • Diagnosis traditionally relies on clinical and electrocardiographical criteria.
  • Molecular genetics has identified specific genes linked to LQTS.

Purpose:

  • To retrospectively analyze genotype-phenotype correlations in pediatric LQTS patients.
  • To evaluate the role and limitations of genetic testing in diagnosing LQTS.
  • To assess the relationship between genotype, symptoms, and cardiac events.

Summary:

  • A retrospective study analyzed 23 pediatric LQTS patients (<21 years) with an average 2-year follow-up.
  • Genotyping revealed mutations in implicated genes (e.g., SCN5A, KCNE2), with two deaths linked to specific mutations.
  • Symptomatic patients showed longer QT/QTc intervals, though not significantly different; LQT3 and double mutations correlated with increased cardiac arrest risk.
  • Notably, three patients had no identified mutation but still experienced severe cardiac events, highlighting diagnostic limitations.

Impact:

  • This study underscores the importance of integrating genetic analysis with clinical and ECG findings for accurate LQTS diagnosis.
  • It emphasizes that genetic testing alone may not capture all cases, necessitating a comprehensive diagnostic approach.
  • Findings contribute to understanding genotype-specific severity and guiding risk stratification in pediatric LQTS.